title: Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties.
abstract: Urinary tract infections (UTIs) are among the most common infectious diseases of humans, with Escherichia coli being responsible for >80% of all cases. Asymptomatic bacteriuria (ABU) occurs when bacteria colonize the urinary tract without causing clinical symptoms and can affect both catheterized patients (catheter-associated ABU [CA-ABU]) and noncatheterized patients. Here, we compared the virulence properties of a collection of ABU and CA-ABU nosocomial E. coli isolates in terms of antibiotic resistance, phylogenetic grouping, specific UTI-associated virulence genes, hemagglutination characteristics, and biofilm formation. CA-ABU isolates were similar to ABU isolates with regard to the majority of these characteristics; exceptions were that CA-ABU isolates had a higher prevalence of the polysaccharide capsule marker genes kpsMT II and kpsMT K1, while more ABU strains were capable of mannose-resistant hemagglutination. To examine biofilm growth in detail, we performed a global gene expression analysis with two CA-ABU strains that formed a strong biofilm and that possessed a limited adhesin repertoire. The gene expression profile of the CA-ABU strains during biofilm growth showed considerable overlap with that previously described for the prototype ABU E. coli strain, 83972. This is the first global gene expression analysis of E. coli CA-ABU strains. Overall, our data suggest that nosocomial ABU and CA-ABU E. coli isolates possess similar virulence profiles.
authors.affiliation: School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD, Australia.
authors.forename: Rebecca E
authors.initials: RE
authors.lastname: Watts
authors.forename: Viktoria
authors.initials: V
authors.lastname: Hancock
authors.forename: Cheryl-Lynn Y
authors.initials: CL
authors.lastname: Ong
authors.forename: Rebecca Munk
authors.initials: RM
authors.lastname: Vejborg
authors.forename: Amanda N
authors.initials: AN
authors.lastname: Mabbett
authors.forename: Makrina
authors.initials: M
authors.lastname: Totsika
authors.forename: David F
authors.initials: DF
authors.lastname: Looke
authors.forename: Graeme R
authors.initials: GR
authors.lastname: Nimmo
authors.forename: Per
authors.initials: P
authors.lastname: Klemm
authors.forename: Mark A
authors.initials: MA
authors.lastname: Schembri
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001437:Bacteriuria / Q000382:microbiology*; D018441:Biofilms; D002408:Catheters, Indwelling / Q000382:microbiology; D024881:Drug Resistance, Bacterial / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity; D005260:Female; D020869:Gene Expression Profiling; D005798:Genes, Bacterial; D006801:Humans; D007501:Iron / Q000378:metabolism; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D010802:Phylogeny; D014546:Urinary Catheterization; D037521:Virulence Factors / Q000235:genetics; D018440:beta-Lactam Resistance / Q000235:genetics
chemical_list: D037521:Virulence Factors; D007501:Iron
references.citation: Infect Immun. 1981 Feb;31(2):564-70
references.pmid: 7012012
references.citation: Clin Infect Dis. 2010 Mar 1;50(5):625-63
references.pmid: 20175247
references.citation: Int J Med Microbiol. 2009 Jan;299(1):53-63
references.pmid: 18706859
references.citation: Curr Opin Infect Dis. 2010 Feb;23(1):76-82
references.pmid: 19926986
references.citation: Infect Immun. 2006 Jan;74(1):615-24
references.pmid: 16369018
references.citation: PLoS Pathog. 2009 Feb;5(2):e1000305
references.pmid: 19229321
references.citation: J Infect Dis. 2002 Oct 1;186(7):1039-42
references.pmid: 12232848
references.citation: Infect Immun. 2007 Jul;75(7):3233-44
references.pmid: 17420234
references.citation: Infect Immun. 2006 Jan;74(1):781-5
references.pmid: 16369040
references.citation: Infect Immun. 1999 Feb;67(2):546-53
references.pmid: 9916057
references.citation: J Clin Microbiol. 1987 Dec;25(12):2253-7
references.pmid: 2892855
references.citation: Microbiology (Reading). 2008 Jan;154(Pt 1):167-175
references.pmid: 18174135
references.citation: Acta Paediatr Scand. 1975 May;64(3):432-6
references.pmid: 1098383
references.citation: J Infect Dis. 1998 Mar;177(3):642-50
references.pmid: 9498443
references.citation: J Infect Dis. 1982 Dec;146(6):719-23
references.pmid: 6815281
references.citation: J Clin Microbiol. 1998 Jan;36(1):115-7
references.pmid: 9431932
references.citation: J Clin Microbiol. 2006 Dec;44(12):4589-92
references.pmid: 17065267
references.citation: FEMS Immunol Med Microbiol. 2007 Oct;51(1):212-9
references.pmid: 17645737
references.citation: J Bacteriol. 1998 May;180(9):2442-9
references.pmid: 9573197
references.citation: Infect Immun. 2000 May;68(5):3040-7
references.pmid: 10769012
references.citation: J Infect Dis. 1987 Jun;155(6):1151-8
references.pmid: 3572035
references.citation: Mol Microbiol. 2000 Nov;38(3):456-64
references.pmid: 11069670
references.citation: J Urol. 2000 Mar;163(3):872-7
references.pmid: 10687996
references.citation: Infect Immun. 2007 Feb;75(2):966-76
references.pmid: 17145952
references.citation: Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S26-9
references.pmid: 16843646
references.citation: Microb Pathog. 1993 Aug;15(2):121-9
references.pmid: 7902954
references.citation: Infect Immun. 2008 Feb;76(2):695-703
references.pmid: 18039831
references.citation: N Engl J Med. 1980 Aug 7;303(6):316-8
references.pmid: 6991947
references.citation: Clin Microbiol Rev. 1991 Jan;4(1):80-128
references.pmid: 1672263
references.citation: FEMS Microbiol Rev. 1990 Mar;6(1):45-56
references.pmid: 2186760
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
references.pmid: 10829079
references.citation: Eur J Epidemiol. 1996 Apr;12(2):191-8
references.pmid: 8817199
references.citation: Infect Immun. 1991 Sep;59(9):2915-21
references.pmid: 1879917
references.citation: Pediatr Nephrol. 2006 Mar;21(3):376-81
references.pmid: 16388392
references.citation: Int J Antimicrob Agents. 2007 Nov;30(5):436-42
references.pmid: 17719751
references.citation: J Infect Dis. 2008 Sep 15;198(6):899-906
references.pmid: 18643750
references.citation: Appl Environ Microbiol. 2000 Oct;66(10):4555-8
references.pmid: 11010916
references.citation: J Infect Dis. 1977 Aug;136 Suppl:S151-60
references.pmid: 330774
references.citation: Infect Immun. 2000 May;68(5):2638-46
references.pmid: 10768955
references.citation: Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S91-107
references.pmid: 16829052
references.citation: J Infect Dis. 2004 Nov 15;190(10):1739-44
references.pmid: 15499527
references.citation: Microbiology (Reading). 2006 Jun;152(Pt 6):1799-1806
references.pmid: 16735742
references.citation: Clin Microbiol Rev. 2008 Jan;21(1):26-59
references.pmid: 18202436
references.citation: J Infect Dis. 1987 Jul;156(1):225-9
references.pmid: 2885379
references.citation: Cell Microbiol. 2001 Apr;3(4):255-64
references.pmid: 11298649
references.citation: J Infect Dis. 2000 Jan;181(1):261-72
references.pmid: 10608775
references.citation: J Bacteriol. 2008 Feb;190(3):1054-63
references.pmid: 18055599
references.citation: Am J Med. 1991 Sep 16;91(3B):65S-71S
references.pmid: 1928194
references.citation: Infect Immun. 2006 Jun;74(6):3565-75
references.pmid: 16714589